Learn To Invest
Stocks Special Reports LICs Credit Funds ETFs Tools SMSFs
Video Archive Article Archive
News Stocks Special Reports Funds ETFs Features SMSFs Learn
About

Company News Summary

Healthscope Reports NPAT of $236.6m for Half-Year to 31 December 2018

14 Mar 2019  |  19:32:00  |  Associate analysts  |  Increase  |  Decrease  |  

Original announcement: Half Yearly Report and Accounts

Healthscope reported NPAT of $236.6m for the half-year ended 31 December 2018. Revenue from ordinary activities were $1,224.6m, up 3% from last year. Diluted EPS was 13.5 cents compared to 4.55 cents last year. Net operating cash flow was $157.1m compared to $170.6m last year. The interim dividend declared was 3.5 cents, compared with 3.2 cents last year.

Healthscope Half Year Results to 31 December 2018

6 Months to 31 December 2018 ($A'000) 6 Months to 31 December 2017 ($A'000)
Revenue 1,224,600 1,189,400
Pre-Tax Profit 95,900 102,400
Net Profit 236,600 79,100
Operating Cash Flow 157,100 170,600
Interim Dividends (cents) 3.5 3.2
Diluted EPS (cents) 13.5 4.534
NTA (cents) 42 37
Please click here for full details

See more ASX300 News Announcements